Chengyan Wang

1.1k total citations
41 papers, 797 citations indexed

About

Chengyan Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chengyan Wang has authored 41 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Chengyan Wang's work include Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (4 papers) and Pluripotent Stem Cells Research (4 papers). Chengyan Wang is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (4 papers) and Pluripotent Stem Cells Research (4 papers). Chengyan Wang collaborates with scholars based in China, United States and Australia. Chengyan Wang's co-authors include Jingxuan Pan, Ke Ding, Hongkui Deng, Mingxiao Ding, Xiaomeng Sun, Pengbo Zhang, Liying Du, Zhijia Tan, Jun Yong and Ting Liu and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Hydrogen Energy.

In The Last Decade

Chengyan Wang

38 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyan Wang China 14 533 125 114 103 88 41 797
Divya Sahu United States 15 644 1.2× 78 0.6× 81 0.7× 238 2.3× 113 1.3× 35 968
N. Lale Şatıroğlu-Tufan Türkiye 18 571 1.1× 191 1.5× 139 1.2× 169 1.6× 71 0.8× 42 997
Yuki Otsuki Japan 13 372 0.7× 109 0.9× 148 1.3× 64 0.6× 103 1.2× 43 726
Xiaoyuan Zi China 14 614 1.2× 98 0.8× 117 1.0× 163 1.6× 63 0.7× 20 909
Amanda Del Rosario United States 14 533 1.0× 189 1.5× 126 1.1× 115 1.1× 69 0.8× 23 1.0k
Matthias Schewe Netherlands 5 429 0.8× 280 2.2× 99 0.9× 137 1.3× 92 1.0× 8 733
Octavio Caba Spain 19 436 0.8× 253 2.0× 74 0.6× 157 1.5× 67 0.8× 52 946
Yuan‐Hung Lo United States 12 302 0.6× 299 2.4× 71 0.6× 114 1.1× 85 1.0× 22 664
Jianming Wang China 16 355 0.7× 193 1.5× 60 0.5× 190 1.8× 121 1.4× 39 708
Victoria Sherwood United Kingdom 16 616 1.2× 218 1.7× 48 0.4× 140 1.4× 89 1.0× 19 969

Countries citing papers authored by Chengyan Wang

Since Specialization
Citations

This map shows the geographic impact of Chengyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyan Wang more than expected).

Fields of papers citing papers by Chengyan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyan Wang. The network helps show where Chengyan Wang may publish in the future.

Co-authorship network of co-authors of Chengyan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyan Wang. A scholar is included among the top collaborators of Chengyan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyan Wang. Chengyan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Mengcheng, et al.. (2025). Nanophase as reversible hydrogen trap dominating hydrogen embrittlement susceptibility in thermally aged duplex stainless steel. International Journal of Hydrogen Energy. 196. 152392–152392.
3.
Sun, Shuo, Yu Han, Haiying Li, et al.. (2025). Beyond the genome: epigenetic regulation of immune responses and T cells in brain tumors. Frontiers in Immunology. 16. 1690552–1690552.
5.
Liu, Xueyan, Xuejuan Li, Chengyan Wang, et al.. (2024). The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease. Neural Regeneration Research. 20(11). 3330–3344. 4 indexed citations
6.
7.
Shan, Peng, Jing Liao, Jiayi Li, et al.. (2023). H2S-releasing adhesive hydrogel as oral radioprotectant for gastrointestinal tract radioprotection. Chinese Chemical Letters. 35(1). 108545–108545. 16 indexed citations
9.
Wang, Yubing, Yufei Feng, Hao Peng, et al.. (2023). Bioinformatics-Based Identification of CircRNA-MicroRNA-mRNA Network for Calcific Aortic Valve Disease. Genetics Research. 2023. 1–12. 1 indexed citations
10.
Li, Changtao, Lijuan Pang, Fangfang Jin, et al.. (2023). Integrated Network Analysis to Determine CNN1, MYL9, TAGLN, and SORBS1 as Potential Key Genes Associated with Prostate Cancer. Clinical Laboratory. 69(07/2023). 2 indexed citations
11.
Zhang, Tingjun, Xuefeng Ding, Maoru Zhao, et al.. (2023). Fullerenols Mitigate Radiation‐Induced Myocardial Injury. Advanced Healthcare Materials. 12(29). e2300819–e2300819. 14 indexed citations
12.
Cai, Wenping, et al.. (2023). Integrated bioinformatics analysis of microarray data from non-small cell lung cancer. Cellular and Molecular Biology. 69(7). 218–224. 1 indexed citations
13.
Zhao, Bei, Xiaodan Hui, Lijing Jiao, et al.. (2020). A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells. Frontiers in Pharmacology. 11. 798–798. 29 indexed citations
14.
Zhou, Shu, et al.. (2019). Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma. Molecular Medicine Reports. 20(1). 393–400. 20 indexed citations
15.
Wang, Pengyun, et al.. (2019). C-terminal of E1A binding protein 2 promotes the malignancy of osteosarcoma cells via JAK1/Stat3 signaling. Journal of Cell Communication and Signaling. 14(1). 67–76. 9 indexed citations
16.
Jin, Shan, Lu Zhang, Yuanfeng Wei, et al.. (2019). Pure squamous cell carcinoma of the gallbladder locally invading the liver and abdominal cavity: A case report and review of the literature. World Journal of Clinical Cases. 7(23). 4163–4171. 5 indexed citations
17.
Wang, Chengyan, Xiaoling Zhou, Yuanfeng Wei, et al.. (2019). Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis. Pathology - Research and Practice. 215(10). 152612–152612. 23 indexed citations
18.
Pang, Lijuan, Qiuxiang Li, Shugang Li, et al.. (2016). Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses. Scientific Reports. 6(1). 22179–22179. 46 indexed citations
19.
Pan, Jingxuan, Ke Ding, & Chengyan Wang. (2012). Niclosamide, an old antihelminthic agent, demonstrates antitumor activity by blocking multiple signaling pathways of cancer stem cells. Chinese Journal of Cancer. 31(4). 178–184. 113 indexed citations
20.
Wang, Chengyan, Xuming Tang, Xiaomeng Sun, et al.. (2011). TGFβ inhibition enhances the generation of hematopoietic progenitors from human ES cell-derived hemogenic endothelial cells using a stepwise strategy. Cell Research. 22(1). 194–207. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026